People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Pharmaceuticals, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuraltus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $40.6M | $462.7M | 2009 |
| Allocade Inc | — | Other Technology | Seed | $12.5M | $107.6M | 2011 |
| Targegen Inc | — | Biotechnology | Seed | $3.7M | $165.6M | 2009 |
| Kadmus Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $300K | $14.2M | 2009 |
Annette Bianchi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Annette Bianchi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Walker | 1 | 17 |
| Rick Smith | 1 | 14 |
| Ivor Royston | 1 | 7 |
| David Gold | 1 | 7 |
| Terry Gould | 1 | 6 |
| Roger Sippl | 1 | 4 |
| James Woody | 1 | 4 |
| Arda M. Minocherhomjee | 1 | 3 |
| Jeff Courtney | 1 | 3 |
| James N. Woody | 1 | 3 |
| Andrew E. Senyei | 1 | 3 |
| Robert McNeil | 1 | 3 |
| Ari Azhir | 1 | 3 |
| Dan O'Connell | 1 | 3 |
| Donald Rosenthal | 1 | 2 |
| Phillip Schneider | 1 | 2 |
| John Whelan | 1 | 2 |
| Eve Kurtin | 1 | 2 |
| Gary Wright | 1 | 2 |
| David E. McClure | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.